(Total Views: 97)
Posted On: 09/11/2024 1:28:25 PM
Post# of 29735
$UNCY Big News! Unicycive Therapeutics Announces Submission of the New Drug Application (NDA) to the U.S. FDA for Oxylanthanum Carbonate (OLC) for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
https://finance.yahoo.com/news/unicycive-ther...UPBA--%7EA
https://finance.yahoo.com/news/unicycive-ther...UPBA--%7EA
(0)
(0)Scroll down for more posts ▼
